The Impact of Vaccination With a Serogroup A Meningococcal Conjugate Vaccine on Carriage of Serogroup A Meningococci in Mali and Niger.

Trial Profile

The Impact of Vaccination With a Serogroup A Meningococcal Conjugate Vaccine on Carriage of Serogroup A Meningococci in Mali and Niger.

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Apr 2014

At a glance

  • Drugs Meningococcal vaccine group A conjugate (Primary)
  • Indications Meningococcal group A infections
  • Focus Therapeutic Use
  • Acronyms MenAfriCar
  • Most Recent Events

    • 07 Apr 2014 Results published in the Lancet.
    • 05 Jul 2010 Additional lead trial investigators identified as reported by ClinicalTrials.gov.
    • 05 Jul 2010 Actual initiation date addedd to 1 May 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top